van der Sangen MJC - Search Results

1

The prognostic and predictive effect of body mass index in hormone receptor-positive breast cancer.

Lammers SWM, Geurts SME, van Hellemond IEG, Swinkels ACP, Smorenburg CH, van der Sangen MJC, Kroep JR, de Graaf H, Honkoop AH, Erdkamp FLG, de Roos WK, Linn SC, Imholz ALT, Smidt ML, Vriens IJH, Tjan-Heijnen VCG. Lammers SWM, et al. Among authors: van der sangen mjc. JNCI Cancer Spectr. 2023 Oct 31;7(6):pkad092. doi: 10.1093/jncics/pkad092. JNCI Cancer Spectr. 2023. PMID: 37991939 Free PMC article. Clinical Trial.

2

Staging and management of axillary lymph nodes in patients with local recurrence in the breast or chest wall after a previous negative sentinel node procedure.

Derkx F, Maaskant-Braat AJ, van der Sangen MJ, Nieuwenhuijzen GA, van de Poll-Franse LV, Roumen RM, Voogd AC. Derkx F, et al. Eur J Surg Oncol. 2010 Jul;36(7):646-51. doi: 10.1016/j.ejso.2010.05.009. Epub 2010 May 26. Eur J Surg Oncol. 2010. PMID: 20537838 Free article.

3

Response to "benefit of radiation boost after whole-breast radiotherapy" (Int J Radiat Oncol Biol Phys 2009;75:1029-1034).

Voogd AC, van der Sangen MJ. Voogd AC, et al. Int J Radiat Oncol Biol Phys. 2010 May 1;77(1):316; author reply 316. doi: 10.1016/j.ijrobp.2009.12.027. Int J Radiat Oncol Biol Phys. 2010. PMID: 20394861 No abstract available.

4

[Compliance with the breast cancer guidelines in the region of the Comprehensive Cancer Centre South, 20031/'04].

van den Hurk CJ, van de Poll-Franse LV, Nolthenius-Puylaert MC, Roukema JA, van der Sangen MJ, Nieuwenhuijzen GA, van den Eijnden-van Raaij AJ, Coebergh JW. van den Hurk CJ, et al. Ned Tijdschr Geneeskd. 2006 Apr 29;150(17):963-8. Ned Tijdschr Geneeskd. 2006. PMID: 17225737 Dutch.

5

[Thyroid metastases as cause of thyroid swelling].

van der Sangen MJ, Wiggers T, Eggermont AM. van der Sangen MJ, et al. Ned Tijdschr Geneeskd. 1993 Feb 6;137(6):295-8. Ned Tijdschr Geneeskd. 1993. PMID: 8433775 Dutch.

6

Local tumor control in radiation therapy of cancers in the head and neck.

Levendag PC, Nowak PJ, van der Sangen MJ, Jansen PP, Eijkenboom WM, Planting AS, Meeuwis CA, van Putten WL. Levendag PC, et al. Am J Clin Oncol. 1996 Oct;19(5):469-77. doi: 10.1097/00000421-199610000-00009. Am J Clin Oncol. 1996. PMID: 8823474

7

Dose, fractionation and overall treatment time in radiation therapy--the effects on local control for cancer of the larynx.

van Putten WL, van der Sangen MJ, Hoekstra CJ, Levendag PC. van Putten WL, et al. Radiother Oncol. 1994 Feb;30(2):97-108. doi: 10.1016/0167-8140(94)90038-8. Radiother Oncol. 1994. PMID: 8184125

8

Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials.

Oppedijk V, van der Gaast A, van Lanschot JJ, van Hagen P, van Os R, van Rij CM, van der Sangen MJ, Beukema JC, Rütten H, Spruit PH, Reinders JG, Richel DJ, van Berge Henegouwen MI, Hulshof MC. Oppedijk V, et al. J Clin Oncol. 2014 Feb 10;32(5):385-91. doi: 10.1200/JCO.2013.51.2186. Epub 2014 Jan 13. J Clin Oncol. 2014. PMID: 24419108 Clinical Trial.

9

The safety of breast-conserving therapy in patients with breast cancer aged < or = 40 years.

van der Leest M, Evers L, van der Sangen MJ, Poortmans PM, van de Poll-Franse LV, Vulto AJ, Nieuwenhuijzen GA, Brenninkmeijer SJ, Creemers GJ, Voogd AC. van der Leest M, et al. Cancer. 2007 May 15;109(10):1957-64. doi: 10.1002/cncr.22639. Cancer. 2007. PMID: 17394192 Free article.

10

[Breast cancer in young women: epidemiology and treatment dilemmas].

van der Sangen MJ, Voogd AC, van de Poll-Franse LV, Tjan-Heijnen VC. van der Sangen MJ, et al. Ned Tijdschr Geneeskd. 2008 Nov 15;152(46):2495-500. Ned Tijdschr Geneeskd. 2008. PMID: 19055255 Review. Dutch.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

99 results

Search Page